FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30933211000001107: Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 21-Feb 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    95556401000001114 Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    95556501000001113 Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Is a Alogliptin 12.5mg tablets false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Has active ingredient Alogliptin false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Has specific active ingredient Alogliptin benzoate false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Has basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) 28 tablet Has AMP False Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start